SSR240612 (10 mg/kg, p.o.)reduced significantly hyperglycemia in STZ-treated rats at 3 h post-gavage; the inhibitory effect of the B1R antagonist was not significant at 6 h and was completely resolved at 24 h. The gene discussed is BDKRB1; the disease is Hyperglycemia.